to evaluate the therapeutic effectiveness of intravenous bretylium tosylate as a first-line drug for patients in cardiopulmonary arrest , a randomized , double-blind study was conducted , comparing bretylium with a normal saline placebo .
C0006168
bretylium tosylate
C0054040
normal saline